Looking into purchasing some shares in this company. The investor presentation refers to targeting NDA filing at the beginning of 2025 (FDA) and targeting filing mid 2025 (TGA). Does this mean the company will need to run further trials after this latest trial? The materials refer to initial sales under Australia's early access scheme.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $38.62M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 34.5¢ | $179.4K | 508.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 65456 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 27806 | 2 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| LTP (ASX) Chart |